Following Andy Burnham's meeting with Arichie Goodburn and the announcement of a national brain cancer lead and accelerated MHRA reviews, chief scientific officer at CRISM Therapeutics Chris McConville gave his insight regarding the news.
Vetter, a global Contract Development and Manufacturing Organisation (CDMO), has received a Red Dot Award in the category "Design Concept" for its next-generation syringe closure system, V-OVS next.
Dan Williams PhD, CEO at SynaptixBio discusses current approaches to delivering drugs into the central nervous system (CNS), focusing on the specific challenges for key therapies like gene-silencing drugs that aim to treat rare neurological diseases.
Bespak has announced the signing of a Memorandum of Understanding (MOU) with Shin Nippon Biomedical Laboratories (SNBL) under which Bespak will offer immediate and exclusive global access to SNBL's proprietary nasal dry powder delivery device.
Bespak has announced the continued expansion of its next-generation nasal drug delivery offering with the launch of NasaDose Ultra Soft Unit Dose Spray.
SPI Pharma, a developer of excipients, drug delivery technologies, vaccine adjuvants, and antacid actives, has unveiled a new brand identity that reflects the company's evolution.
Timothy Steckler, Ph.D., applications technology manager and Benny David, Ph.D., director, global business development at NuSil explore how silicone materials are expanding the formulator's toolbox.
Joel Pike, senior global product manager, Avantor looks at the role of excipients in enabling the shift from intravenous to subcutaneous drug delivery.
Lubrizol will showcase its portfolio of multifunctional excipients at CPHI Milan (6-8th October), and demonstrate how they solve diverse drug delivery challenges.
Prabhakar Reddy, PhD, senior director, Pharmaceutical Science General Chapters & Complex Generics, USP discusses how complex formulations demand a new approach to quality and standardisation.
